Relative Strength Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 2.990 USD | -4.17% |
|
-3.55% | +8.73% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -4.17% | -3.55% | +8.73% | -12.83% | -55.95% | 356M |  |  |  |
- Stock Market
- Stocks
- CATX Stock
- Charts Perspective Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
